Lipoprotein(a) in neoplastic transformation
- 7 September 2025
- journal article
- review article
- Published by Elsevier in Clinica Chimica Acta
- Vol. 579, 120581
Abstract
No abstract availableKeywords
Funding Information
- Hainan Province Natural Science Foundation (821QN425)
- Key Research and Development Project of Hainan Province (ZDYF2024SHFZ111)
- Key Research and Development Project of Hainan Province (ZDYF2025SHFZ017)
This publication has 43 references indexed in Scilit:
- Lipoprotein(a) and Calcific Aortic Valve Stenosis ProgressionJAMA Cardiology, 2024
- Lipoprotein (a)-Related Inflammatory Imbalance: A Novel Horizon for the Development of AtherosclerosisCurrent Atherosclerosis Reports, 2024
- Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)JAMA, 2023
- Muvalaplin, an Oral Small Molecule Inhibitor of Lipoprotein(a) FormationJAMA, 2023
- Lipoprotein(a) and its Significance in Cardiovascular DiseaseJAMA Cardiology, 2022
- Lipoprotein(a) and ethnicitiesAtherosclerosis, 2022
- Association of total cholesterol, low‐density lipoprotein cholesterol, and non‐high‐density lipoprotein cholesterol with atherosclerotic cardiovascular disease and cancer in a Chinese male populationInternational Journal of Cancer, 2017
- Associated Risk of Malignancy in Patients with Cardiovascular Disease: Evidence and Possible MechanismThe American Journal of Medicine, 2017
- Blood lipid profiles in children with acute lymphoblastic leukemiaCancer, 1998
- Lipoprotein(a) and CA125 levels in the plasma of patients with benign and malignant ovarian diseaseInternational Journal of Cancer, 1992